AAV serotype 2 vectors preferentially integrate into active genes in mice
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Recombinant adeno-associated virus serotype 2 (rAAV2) is a promising vector for gene therapy because it can achieve long-term stable transgene expression in animals and human subjects after direct administration of vectors into various target tissues. In the liver, although stable transgene expression primarily results from extrachromosomal vector genomes, a series of experiments has shown that vector genomes integrate into host chromosomes in hepatocytes at a low frequency. Despite the low integration efficiency, recent reports of retroviral insertional mutagenesis in mice and two human subjects have raised concerns about the potential for rAAV2-mediated insertional mutagenesis. Here we characterize rAAV2-targeted chromosomal integration sites isolated from selected or non-selected hepatocytes in vector-injected mouse livers. We document frequent chromosomal deletions of up to 2 kb at integration sites (14 of 14 integrations, 100%; most of the deletions were <0.3 kb) and preferred integration into genes (21 of 29 integrations, 72%). In addition, all of the targeted genes analyzed (20 of 20 targeted genes, 100%) were expressed in the liver. This is the first report to our knowledge on host chromosomal effects of rAAV2 integration in animals, and it provides insights into the nature of rAAV2 vector integration into chromosomes in quiescent somatic cells in animals and human subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yet, follow-up studies indicated that 53-62% of rAAV integrations in the liver fused into actively-transcribed genes, and 3-8% into ribosomal DNA [247].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [247]
In the citing paper
“preclinical data suggest AAV integration events occur in a dose-dependent manner with a preference for integration at sites of active transcription, tissue-specific promoters are protective against oncogenesis.178, 179, 180”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [180]
In the citing paper
“This number is similar to multiple estimates of random integration of AAV8 from the literature.35”
From Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo†‡ (2010) · cites this paper as [35]
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Large-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466
Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., Glader, B., Chew, A. J., J Tai, S., Herzog, R. W., et al. (2000) · Nature Genetics · doi:10.1038/73464 · Cited by 1,022 · cited 1×
“jpg" NDATA ITEM> ]> Recombinant adeno-associated virus serotype 2 (rAAV2) is a promising vector for gene therapy because it can achieve long-term stable transgene expression in animals and human subjects after direct administration of vectors into various target tissue”
BackgroundSelf-citationOverturf, K., Al-Dhalimy, M., Tanguay, R., Brantly, M., Ou, C.-N., Finegold, M., & Grompe, M. (1996) · Nature Genetics · doi:10.1038/ng0396-266 · Cited by 549 · cited 1×
“Because there is a selective repopulation of stable genetically modified FAH-positive hepatocytes in HTI mouse liver”
BackgroundSelf-citationMurine leukemia induced by retroviral gene marking
Li, Z., Düllmann, J., Schiedlmeier, B., Schmidt, M., von Kalle, C., Meyer, J., Forster, M., Stocking, C., Wahlers, A., Frank, O., et al. (2002) · Science · doi:10.1126/science.1068893 · Cited by 525 · cited 1×
“Despite the low integration efficiency, recent reports of retroviral insertional mutagenesis in mic”
BackgroundNakai, H., Yant, S. R., Storm, T. A., Fuess, S., Meuse, L., & Kay, M. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6969-6976.2001 · Cited by 478 · cited 1×
“In the liver, although stable transgene expression primarily results from extrachromosomal vector genome”
BackgroundSelf-citationSOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data
Diehn, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg014 · Cited by 428 · cited 1×
“We assessed the transcriptional activity of each targeted gene using web-based public databases and browsers: NCBI UniGene, SOURC”
Method
Cited by
Items 301–400 of 400
Safety of Adeno-Associated Viral Vectors
Lin, S., & Ertl, H. C. J. (2008) · Future Virology · doi:10.2217/17460794.3.5.491 · Cited by 3
“This region is rich in miRNA and small nucleolar RNA encoding sequences, which are overexpressed upon integration of the rAAV vector’s genome [31,32].”
BackgroundYang, D., Liao, R., Zheng, Y., Sun, L. V., & Xu, T. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.15589 · Cited by 3
“It has been reported that both transposons and retroviruses preferably insert into transcriptionally active genes, which may be due to the higher accessibility of open chromatin and/or the interaction between transposase/integrase and cellular proteins bound to transcriptionally active regions (1-6).”
BackgroundGene Therapy for Ocular Diseases
Kim, B. J., & Waheed, N. K. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780195326147.003.0052 · Cited by 3
Nakai, H. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_23 · Cited by 3
Self-citationGene Therapy of Skeletal Muscle Disorders Using Viral Vectors
Arnett, A. L. H., Ramos, J. N., & Chamberlain, J. S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00076-4 · Cited by 3
Ozawa, K. (2007) · Uirusu · doi:10.2222/jsv.57.47 · Cited by 6
Hubner, E. K., Lechler, C., Kohnke‐Ertel, B., Zmoos, A., Sage, J., Schmid, R. M., & Ehmer, U. (2016) · The Journal of Gene Medicine · doi:10.1002/jgm.2940 · Cited by 4
Ectopic expression of factor VIII in MSCs and hepatocytes derived from rDNA targeted hESCs
Sun, Q., Liu, X., Wu, Y. C., Niu, W., Long, P., Liu, J., Lei, M., Hu, Y., Wu, L., Li, Z., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.08.007 · Cited by 3
Gene therapy and CVD: how near are we?
Steer, C. J., & Kren, B. T. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.03.004 · Cited by 3
Adeno-associated viruses in gene therapy for spinal muscular atrophies: trend or triumph?
Slobodkina, E. A., Akopyan, Z. A., & Макаревич, П. И. (2023) · Genes and Cells · doi:10.17816/gc516537 · Cited by 2
“Случаев прямого онкогенного действия ААВ у человека не описано [39], однако известны крайне редкие случаи интеграции трансгена ААВ в геном других млекопитающих [40, 41].”
Qiu, B., Lorino, M., Li, Y., He, Z., Wang, X., Wang, W., & Lara‐Sáez, I. (2026) · The Journal of Gene Medicine · doi:10.1002/jgm.70087 · Cited by 2
Modulation of AAV transduction and integration targeting by topoisomerase poisons
Kasimsetty, A., Hwang, Y., Everett, J. K., McFarland, A. G., Zolnoski, S. A., Lu, T., Roche, A. M., Martínez‐García, P. M., Sabatino, D. E., & Bushman, F. D. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101364 · Cited by 2
Recombinant adeno-associated virus vectors for somatic gene therapy in dermatology
Braun‐Falco, M., & Roedl, D. (2007) · Expert Review of Dermatology · doi:10.1586/17469872.2.2.167 · Cited by 2
Russell, S. J., & Peng, K. W. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50097-4 · Cited by 2
Genetics of Hypertension and Cardiovascular Disease
Katsuya, T., Harrap, S. B., & Ogihara, T. (2010) · International Journal of Hypertension · doi:10.4061/2010/951254 · Cited by 3
Chansel‐Debordeaux, L., Bourdenx, M., Dutheil, N., Doveró, S., Canron, M., Jimenez, C., Bézard, E., & Dehay, B. (2018) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.192.r3 · Cited by 2
“Since rAAVs integrate only at low frequency into the genome, 28–32 it was checked that, despite such EGFP immunopositivity, the offspring would not express the transgene.”
Targeted gene therapy of autoimmune diseases: advances and prospects
Creusot, R. J., Fathman, C. G., Müller‐Ladner, U., & Tarner, I. H. (2005) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.1.3.385 · Cited by 2
Breastfeeding During Pregnancy: Opinions and Behaviors of Mothers
KARAMAN, P. D., & Özsoy, S. (2025) · Bezmialem Science · doi:10.14235/bas.galenos.2024.12599 · Cited by 1
Scott, S., Hallwirth, C. V., Sasaki, N., Cunningham, S. C., Zhu, E., Khandekar, N., Kizana, E., Baruteau, J., Gissen, P., Perocheau, D. P. B., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.07.039 · Cited by 1
Bakhshinejad, B., Javidi, M. A., Babashah, S., & Babashah, S. (2014) · Springer eBooks · doi:10.1007/978-3-319-03725-7_16 · Cited by 1
Lambert, M. S. (2008) · Applied Biosafety · doi:10.1177/153567600801300109 · Cited by 1
Gene therapy to the kidney using viral vectors.
Akbulut, T., & Park, F. (2008) · PubMed · Cited by 1
Gene Silencing Methods Using Vector‐Encoded siRNAs or miRNAs
Liu, Y. P., & Berkhout, B. (2014) · Wiley eBooks · doi:10.1002/9783527647064.ch55 · Cited by 1
Using Factor VII in Hemophilia Gene Therapy
Kazemi, B. (2011) · InTech eBooks · doi:10.5772/17695 · Cited by 1
“Methods proposed for the future: reviewing the history of hemophilia gene therapy by viral vectors, identified several reasons that cannot be sure of the viruses used for gene transfer: 1) Application of viruses is associated with inappropriate chromosomal insertion and makes the undesirable point mutations (Nakai et…”
BackgroundTargeting site-specific chromosome integration.
Nuno-Gonzalez, P., Chao, H., & Oka, K. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3441 · Cited by 3
Immune System Obstacles to In vivo Gene Transfer with Adeno-Associated Virus Vectors
Büning, H., & Mingozzi, F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00004-x · Cited by 1
Polyamine-Based Agents for Gene and siRNA Transfer
Blagbrough, I. S., Metwally, A. A., & Ahmed, O. A. A. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733090-00205 · Cited by 3
Adeno Associated Viral Vectors for the Nervous System
Kaspar, B. K., & Gage, F. H. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-4 · Cited by 1
Targeted Gene Modification of the Nervous System
Cortés, M. L., & Breakefield, X. O. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-7 · Cited by 1
Gene therapy using AAV (adeno-associated virus) vectors
Ozawa, K. (2003) · Uirusu · doi:10.2222/jsv.53.163 · Cited by 1
Viral Vector Delivery to Dividing Cells
Saeki, Y. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-021-8_33 · Cited by 1
Chromosomal integration in vitro and in vivo of high capacity adenoviral vectors
Stephen, S. L. (2007) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Studies on viral gene transfer and angiogenesis inhibition in experimental glioma models
Huszthy, P. C. (2006) · NORA - Norwegian Open Research Archives
Philippe, S. (2007) · HAL · Cited by 2
Development of Therapies for Spinal Muscular Atrophy Using Gene Therapy and Nanotechnology
Little, D. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Soci, Ú. P. R. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2015.tde-16032015-162042
Adeno‐associated viral vectors: depend(o)ble stability
Snyder, R. O. (2005) · Wiley eBooks · doi:10.1002/047001153x.g107313
Silcox, C. E. (2014) · DSpace@MIT (Massachusetts Institute of Technology)
Use of Gene Transfer to Study HDL Remodeling
Oka, K., & Chan, L. (2007) · Wiley eBooks · doi:10.1002/9783527625178.ch9
Huntington's disease modeling and treatment : from primary neuronal cultures to rodents
Zala, D. (2005) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · doi:10.5075/epfl-thesis-3137 · Cited by 2
Integrating Viral Vectors for Gene Modifications
Mendel, G. L., Paszkiet, B., & Witek, R. P. (2011) · Wiley eBooks · doi:10.1002/9781118147177.ch9
Mutational analysis of PhiC31 integrase to improve gene therapeutic applications
Liesner, R. (2010) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.12243
Maina, C. N. (2009) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1689
Oncolytic adenovirus vectors for nitroreductase suicide gene therapy of prostate cancer
Herod, M. R. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham)
Improving gene transfer into skeletal muscle through genetic retargeting of adenoviral vectors
Thirion, C. (2004) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.6339
Gene Transfer and the Cardiovascular System
Miller, W. H., Nicklin, S. A., Baker, A. H., & Dominiczak, A. F. (2005) · Humana Press eBooks · doi:10.1385/1-59259-883-8:175
“For specific integration to occur, the rep protein must be present—integration otherwise occurs semirandomly, with a preference for active genes ( 25 ).”
BackgroundAdenovirus-based gene therapy approaches for hemophilia B
Zhang, W. (2012) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.14566
Development and Application of Gene Therapy Technologies
Ozawa, K. (2004) · Uirusu · doi:10.2222/jsv.54.49
Müller, O. J., & Katus, H. A. (2008) · Springer eBooks · doi:10.1007/978-3-540-78709-9_9
“It has been shown that AAV vectors are able to integrate into active genes (Nakai et al. 2003).”
BackgroundCut-and-paste therapy fixes mouse haemophilia
Weaver, J. (2011) · Nature · doi:10.1038/news.2011.384
Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der
Bonn, R. F.-W.-U. (2012) · Cited by 1
Genetic Manipulation of Human Embryonic Stem Cells
Placantonakis, D. G., Tomishima, M. J., Lafaille, F. G., & Studer, L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-227-8_7
“AAV has been shown to integrate into transcriptionally active regions of the host genome [59].”
BackgroundVector-based antiviral therapy
Ensser, A. (2006) · Springer eBooks · doi:10.1007/978-0-387-31047-3_19
“Reports by the Kay group provided insights into the nature of rAAV2 vector integration into chromosomes in quiescent somatic cells in animals and human subjects (Nakai et al., 2003), describing the host chromosomal effects of rAAV2 integration in mice.”
BackgroundrAAV-based gene therapy for molybdenum cofactor deficiency type B
Jakubiczka-Smorag, J. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5161
Bakhshinejad, B., Javidi, M. A., Babashah, S., & Babashah, S. (2014)
Anti-Angiogenic Gene Therapy: Basic Science and Challenges for Translation into the Clinic
Lange, C., & Bainbridge, J. W. (2016) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-319-24097-8_11
Gene Therapy Applications for Parkinson’s Disease
Torres, E. M., Monville, C., & Dunnett, S. B. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-10
Genetic manipulation of the pancreas
Ayuso, E., & Bosch, F. (2007)
Optic nerve regeneration in adult rat
Hu, Y. (2006) · UWA Profiles and Research Repository (UWA)
Nault, J. (2015) · theses.fr (ABES) · doi:10.70675/1be42c8azb025z49fczabeczf2d92c0f0126 · Cited by 2
Biological Therapies for the Treatment of Cardiac Arrhythmias
Boveri, L., Colombi, B., & Priori, S. G. (2007)
Gene Therapy Approaches for Neurological Lysosomal Storage Diseases
McCurdy, V. J. (2014)
Novel piggyBac transposase vectors for safer gene addition into mammalian genomes
Owens, J. B. (2014) · ScholarSpace (University of Hawaii at Manoa)
Stem Cells in the Liver Cancer and the Organ Size Control
Tiyaboonchai, A., Su, Y., & Li, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812301-0.00004-9
Novel Approaches for Pluripotent Reprogramming
Weltner, J. (2018) · Helda - University of Helsinki Institutional Repository · Cited by 1
Monteillet, L. (2019) · theses.fr (ABES) · doi:10.70675/e81d5d41z63f6z4620za1ccz4e8ad6a0bfdc · Cited by 2
A novel cell and gene therapy approach for Friedreich's ataxia
Shaban, E. (2020) · Brunel University Research Archive (BURA) (Brunel University London)
In Utero Stem Cell Transplantation, Enzyme Replacement, and Gene Therapy
MacKenzie, T. C., & Schwab, M. E. (2021) · Wiley eBooks · doi:10.1002/9781119676980.ch30
マルチトーン信号のピーク対平均電力比(PAPR)を低減する初期位相設定法
楢橋, 祥., & 野島, 俊. (1995) · Cited by 3
Cell disorders in lysosomal storage diseases
Roy, E. (2012) · theses.fr (ABES) · doi:10.70675/bf977698z4d47z4ca2zbf59zf7160f091f3d · Cited by 1
Oligonucleotide-mediated gene editing of Apolipoprotein A-I
Disterer, P. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique) · doi:10.13140/rg.2.2.33176.80648
Mingozzi, F., & Junge, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-63671-1.00033-1
Tattersall, P. J., & Cotmore, S. F. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0227
Molecular Analysis of Chromosomal Rearrangements in Mammalian Cells After � C31-Mediated Integration
Ehrhardt, A., Engler, J. A., Xu, H., Cherry, A. M., & Kay, M. A. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-256
Self-citationGenome Integration of Adeno-associated Virus (AAV) Vectors into Infected Cells
Hirai, Y. (2023) · Nihon Ika Daigaku Igakkai Zasshi · doi:10.1272/manms.19.211
rAAV Integration: Detection and Risk Assessment
Yuan, J., Gil-Fariña, I., Fronza, R., & Whiteley, L. O. (2024) · Wiley eBooks · doi:10.1002/9781119852810.ch13
GENE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS IN NZB/W F1 MICE
Ye, X. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Walsh, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00013-0
Breton, C. A., Clark, P., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · Figshare · doi:10.6084/m9.figshare.11999370
Breton, C. A., Clark, P. M., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · Figshare · doi:10.6084/m9.figshare.11999367
Breton, C. A., Clark, P., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · Figshare · doi:10.6084/m9.figshare.11999373
Potential effects of endogenous RNA/DNA hybrids on CRISPR-Cas9-mediated homology-directed repair
Puzzo, F., Bayram, B., Macaubas, C., Lin, A., Jang, H., Zhang, F., Mellins, E., & Kay, M. A. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102880
Self-citationDevelopment of a Novel Method to Detect AAV Vector Integration
Zhang, J., Dang, T. T., Lin, T., Yu, X., Pellin, D., Tian, J., Simmons, O., Kou, E., Cornetta, K. G., & Xiao, W. (2026) · Viruses · doi:10.3390/v18030315
“Integration occurs at sites of double-stranded breaks with a propensity for transcriptionally active areas, CpG islands, and transcription start sites [5–8].”
Chansel‐Debordeaux, L. (2017) · theses.fr (ABES) · doi:10.70675/6b80556ez59a7z4009za535zb2fd974484d2
Double approche à la thérapie anti-tumorale à l'aide de vecteurs lentiviraux
Coulibaly, T. G. S. (2017) · theses.fr (ABES) · doi:10.70675/19a656d4z4de3z4664z8f90z856d75d1ba99
Bella, T. L. (2018) · theses.fr (ABES) · doi:10.70675/e88d9a08za929z4c0fzb8d9z9f01cd69ca39
Synaptopathies auditives et vestibulaires : de la physiologie moléculaire à la thérapie génique
Calvet, C. (2020) · theses.fr (ABES) · doi:10.70675/8920e327zd8ffz457ez9711zcfc53af428dc
Joschko, C. P., Wang, C.-C., van Buiten, A., Goris, M., Hoogstra‐Berends, F., Wang, J., Bacurio, J. H. T., Chen, Y., Jia, N., Deng, J., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073338
“CBS staining revealed no clusters of adjacent CBS-expressing cells, suggesting that genomic integration of the vector DNA and clonal expansion, which has been reported at low levels in the liver for the related AAV serotype 2 [28], is unlikely.”
Liu, B., Klatt, D., Harris, C. E., McGuinness, M. K., Brendel, C., & Williams, D. A. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag500
“Adeno-associated virus-based vectors enable efficient delivery to non-dividing cells and are typically regarded as non-integrating; however, rare but detectable integration events have been reported, particularly in the context of genome editing [ 28–31 ].”
Plasticity of colorectal cancer cells : impact of Cdx2, a critical factor for intestinal identity
Hinkel, I. (2012) · theses.fr (ABES) · doi:10.70675/c1811327zbf2dz45aez9b71z727576344f65
The Therapeutic potential of lentivector-delivered RNAi
Casey, N. (2010) · UTAS Research Repository · doi:10.25959/23209826
Sarkis, C., & Mallet, J. J. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.023
Metadata
- Authors
- Nakai, H., Montini, E., Fuess, S., Storm, T. A., Grompe, M., & Kay, M. A.
- Affiliations
- Stanford Medicine (US)
- Oregon Health & Science University (US)
- Corresponding author
- Kay, Mark A
- Venue
- Nature Genetics
- Published
- 2003-06-01
- Volume
- 34
- Issue
- 3
- Pages
- 297-302
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2171427593
- Cited by
- 392
- References
- 29
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 13 · 2023: 12 · 2022: 11 · 2021: 11 · 2020: 18 · 2019: 8 · 2018: 10 · 2017: 10 · 2016: 8 · 2015: 13 · 2014: 8 · 2013: 7 · 2012: 19
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- AAV2, rAAV2, chromosomal integration, insertional mutagenesis, gene therapy vectors, hepatocytes, liver, somatic cells, transgene expression
- MeSH terms
- Dependovirus, Animals, Base Sequence, Cell Line, Chromosome Deletion, Chromosomes, Female, Genes, Genetic Vectors, Humans, Mice, Inbred C57BL, Molecular Sequence Data, Plasmids, Sequence Homology, Nucleic Acid, Transduction, Genetic, Genetic Therapy, Virus Integration, Gene Transfer Techniques, Transgenes, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.